CCL13 抗体 (Middle Region)
Our Local Distributor
北京 101111
Quick Overview for CCL13 抗体 (Middle Region) (ABIN926919)
抗原
See all CCL13 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- Middle Region
-
纯化方法
- Purified
-
免疫原
- CCL13 antibody was raised in rabbit using the middle region of CCL13 as the immunogen
-
-
-
-
应用备注
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
说明
-
CCL13 Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this CCL13 antibody
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
浓度
- Lot specific
-
缓冲液
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
注意事项
- Avoid repeated freeze/thaw cycles.
-
储存条件
- 4 °C/-20 °C
-
储存方法
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- CCL13 (Chemokine (C-C Motif) Ligand 13 (CCL13))
-
别名
- CCL13
-
背景
- Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. CCL13 displays chemotactic activity for monocytes, lymphocytes, basophils and eosinophils, but not neutrophils. This chemokine plays a role in accumulation of leukocytes during inflammation. It may also be involved in the recruitment of monocytes into the arterial wall during artherosclerosis. Synonyms: Polyclonal CCL13 antibody, Anti-CCL13 antibody, chemokine, C-C motif ligand 13 antibody, CKb10 antibody, MCP-4 antibody, MGC17134 antibody, NCC-1 antibody, NCC1 antibody, SCYA13 antibody, SCYL1 antibody.
-
途径
- Regulation of Systemic Arterial Blood Pressure by Hormones, The Global Phosphorylation Landscape of SARS-CoV-2 Infection
抗原
-